Can I Use Oral Fluid (Saliva) Drug Testing Yet? (FMCSA / DOT)
Current as of December 2025
FMCSA Rules Made Simple
The Department of Transportation (DOT) has technically authorized oral fluid (saliva) drug testing, but you cannot legally use it yet.
For oral fluid testing to be implemented under DOT rules, the Department of Health and Human Services (HHS) must certify at least two laboratories for oral fluid testing (one for the primary specimen and one for the split specimen). As of the SAMHSA lab resources available in late 2025, there are still zero HHS-certified oral fluid labs.
- Current status: Authorized on paper, but factually impossible to perform.
- Interim requirement: Urine testing rules still control “shy bladder” and suspected tampering situations.
Navigating the Saliva Stalemate
For years, the industry has looked for a less invasive, harder-to-cheat alternative to urine collection. On May 2, 2023, DOT published a final rule (88 FR 27596) amending 49 CFR Part 40 to include oral fluid testing. The rule is “effective,” but implementation is blocked by a regulatory bottleneck tied to laboratory certification.
Under DOT’s rule, employers can’t implement oral fluid testing until there are at least two HHS-certified oral fluid laboratories available—one for the primary test and one for the split specimen test.
So basically… here’s the choke point
DOT’s oral fluid testing framework requires split-specimen protections. That split testing can’t happen unless two certified oral fluid labs exist. Without those labs, the rule exists, but the system can’t function.
Why the Delay? The “Two-Lab” Rule
DOT is strict about the split-specimen protection built into Part 40. This is the safeguard that allows a driver to request independent testing of the split specimen if the primary specimen comes back non-negative.
Because of that protection, DOT won’t allow DOT-regulated employers to start oral fluid testing until two HHS-certified oral fluid labs are available, along with DOT-conforming oral fluid collection devices tied to those labs.
The Medical Card Waiver Extension: A January 2026 Milestone
While the industry waits on oral fluid testing, other compliance items still matter. FMCSA re-issued a temporary waiver allowing interstate CDL holders, CLP holders, and motor carriers to rely on a paper copy of the Medical Examiner’s Certificate (MEC) as proof of medical certification for up to 60 days after issuance. The waiver period runs October 13, 2025 through January 10, 2026.
Okay now… what drivers should do
- Carry the paper MEC after your exam.
- Make sure your carrier keeps a copy in the DQ file (during the covered window).
- Follow up if your SDLA hasn’t updated your record within the allowed timeframe.
Strategic Pivot: Direct Observation and “Shy Bladder”
Until oral fluid testing is legally usable for DOT-regulated testing, you’re still bound by the urine testing procedures in Part 40. If a driver cannot provide a urine specimen (“shy bladder”), you can’t switch to a mouth swab. You must follow the shy bladder protocol, including a waiting period and controlled fluid intake.
And when a collector has reason to believe a specimen was tampered with, the follow-up collection can require direct observation under Part 40, performed by an observer of the same gender.
Think about it like this…
Oral fluid testing is a big deal because it’s observed by nature—without the same-gender observer requirement. That’s why it’s considered a game-changer for real-world operations once it becomes legally usable under DOT rules.
Preparing Your Fleet for the Switch
Don’t wait until labs are certified to get your paperwork ready. You can draft policy language now so you’re not scrambling later. One clean approach is to add a clause like:
The company reserves the right to use either urine or oral fluid testing as permitted under 49 CFR Part 40.
Important: Don’t distribute or implement oral-fluid policy changes until DOT confirms implementation conditions have been met (including the two-lab requirement) and guidance supports employer rollout.
Terms Made Simple
- 49 CFR Part 40: DOT’s procedures for workplace drug and alcohol testing across DOT agencies (FMCSA, FAA, etc.).
- Split Specimen: A second specimen used for independent re-testing if the employee requests it after a non-negative result.
- HHS-Certified Laboratory: A laboratory certified under HHS requirements to conduct federally regulated drug testing.
- DER (Designated Employer Representative): The employer’s official authorized to take immediate action in the testing program.
- Shy Bladder: When a driver can’t provide enough urine for testing under the required collection procedures.
- Direct Observation: A urine collection process where an observer watches the specimen leave the body to prevent tampering.
Helpful Links & Tools
- DOT ODAPC – Part 40 Final Rule Summary (May 2023): View
- Federal Register – Oral Fluid Final Rule (88 FR 27596): View
- eCFR – 49 CFR Part 40 (Current Text): View
- DOT ODAPC – Oral Fluid Collection Procedures Guidelines (Jan 2025 PDF): View
- SAMHSA – Certified Laboratory List (Drug-Free Workplace): View
- Example SAMHSA Certified Lab Listing by State (PDF, May 2025) noting no oral fluid certified labs: View
- FMCSA – Re-issued Temporary Waiver (Oct 13, 2025 – Jan 10, 2026): View
- NRII Waiver PDF (FMCSA National Registry): View
- FMCSA Drug & Alcohol Clearinghouse: Open
- DOT ODAPC (Drug & Alcohol Policy): Open
Stay Ahead of the Inspector
Download your Free DOT Compliance Checklist Bundle and tighten up your DQ files before the next audit.
Sources
- Federal Register — 88 FR 27596 (May 2, 2023) Oral Fluid Final Rule
- DOT ODAPC — Part 40 Final Rule Summary (May 2023)
- eCFR — 49 CFR Part 40 (current text)
- DOT ODAPC — Oral Fluid Specimen Collection Procedures Guidelines (Jan 2025)
- SAMHSA — Certified Laboratory List (Drug-Free Workplace)
- FMCSA — Temporary Waiver (Oct 13, 2025 – Jan 10, 2026)
- FMCSA National Registry — NRII Waiver PDF (Oct 9, 2025)